“Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis” (2023) Archivio Italiano di Urologia e Andrologia, 95(2). doi:10.4081/aiua.2023.11509.